ORIGINAL RESEARCH article
Front. Immunol.
Sec. Cancer Immunity and Immunotherapy
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1601423
This article is part of the Research TopicColorectal Cancer Immunotherapy and Immune MechanismsView all 12 articles
Fusobacterium-associated molecular and immunological alterations in colorectal cancer: Insights from a Norwegian cohort
Provisionally accepted- 1Department of Life Sciences and Health, Oslo Metropolitan University, Oslo, Norway
- 2Department of Pathology, Akershus University Hospital, Lørenskog, Norway
- 3Department of Microbiology and Infection Control, Akershus University Hospital, Lørenskog, Norway
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
The gut microbiome may significantly influence the development of colorectal cancer (CRC), with Fusobacterium species playing a key role. Recent research has identified Fusobacterium animalis as the predominant Fusobacterium species in CRC tumors. This pilot research explores the immunological and molecular interactions associated with F. animalis and other Fusobacterium species in Norwegian CRC patients. Tumor samples from 25 CRC patients were divided by Fusobacterium load and analyzed for molecular alterations, immunological gene expression, and macrophage polarization. Fusobacterium-high tumors were associated with microsatellite instability (MSI). Analysis of differential immune gene expression, combined with correlation analyses, identified 25 genes, including C-X-C motif chemokine ligand 8 (CXCL8), interleukin-6 (IL6), indoleamine 2,3-dioxygenase 1 (IDO1), and secreted phosphoprotein 1 (SPP1), that exhibited significant associations with Fusobacterium abundance in this cohort.Analysis of Fusobacterium adhesion protein 2 (Fap2) revealed active transcription and constitutive expression across multiple colonic sites, including CRC tumor tissues, adjacent nonneoplastic tissues, the ascending colon, and the sigmoid colon. The analysis revealed a positive correlation between RNA levels of Fusobacterium-specific genes (fap2 and nusG) and immune genes (CXCL8, IL6, SPP1, and IDO1) across different colonic sites. This suggests that the abundance of active Fusobacterium cells is related to and possibly influences the proinflammatory response in the colonic microenvironment.Although arginase 1 (ARG1) expression was elevated in Fusobacterium-high tumors, no significant link was found between Fusobacterium abundance and M2 macrophage polarization, contradicting previous studies. The complexity of these interactions may stem from using patient tumor samples instead of CRC-derived cell lines experimentally infected with F. nucleatum.
Keywords: colorectal cancer (CRC), Gene Expression, Immune genes, Fusobacterium, fap2, Norway
Received: 27 Mar 2025; Accepted: 29 Jul 2025.
Copyright: © 2025 Omran, Camacho, Senthakumaran, Gundersen, Alte, Randen, Tunsjø, Sæther and Bemanian. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Thura Akrem Omran, Department of Life Sciences and Health, Oslo Metropolitan University, Oslo, Norway
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.